Clinical utilization and outcomes over eight consecutive years following oocyte cryopreservation
- PMID: 39633145
- PMCID: PMC11871152
- DOI: 10.1007/s10815-024-03334-z
Clinical utilization and outcomes over eight consecutive years following oocyte cryopreservation
Abstract
Objective: To compare embryologic and clinical outcomes following oocyte cryopreservation (OC) and immediate fertilization for embryo cryopreservation (EC) in non-infertile patients.
Design: Retrospective cohort study SUBJECTS: Patients treated at a single fertility center from 2016 to 2023.
Exposure: OC MAIN OUTCOME MEASURES: Blastocyst development was compared between women undergoing OC and non-infertile women undergoing immediate fertilization for EC between 18 and 42 years of age. ICSI, PGT-A, and eSET were used in all cycles.
Results: Outcomes from 3697 thawed MII oocytes obtained from 239 OC patients were compared to 28,959 fresh MII oocytes obtained from 2031 patients undergoing immediate fertilization for EC. Average thaw MII survival rate was 92% and high across age groups. Post-thaw oocytes demonstrate lower fertilization rate compared to fresh oocytes (85% v 90%, p < 0.05). As oocyte age increased, the mean number of MII used per blastocyst increased to a greater extent among thawed compared to fresh oocytes (2.9 v 2.2 MII age 18-34, 3.3 v 2.5 MII age 34-37, 3.9 v 2.9 MII age 38-40, 7.5 v 3.9 MII age 41-42, p < 0.05). Among patients achieving transfer of a euploid blastocyst, clinical pregnancy rate and live birth rate per transfer were similar using thawed and fresh oocytes (p = 0.82 and p = 0.79, respectively).
Conclusions: Blastocyst conversion is lower from thawed oocytes compared to fresh oocytes. Differences in blastocyst development between thawed and frozen oocytes increase with advancing oocyte age, suggesting that older oocytes may be less efficient in their conversion to blastocysts after vitrification and warming.
Keywords: Assisted reproductive technology; Egg freezing; Fertility preservation; Oocyte cryopreservation; Oocyte thaw.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Attestation statement: Data regarding any of the subjects in the study has not been previously published unless specified. Data will be made available to the editors of the journal for review or query upon request. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.Hum Reprod Update. 2017 Mar 1;23(2):139-155. doi: 10.1093/humupd/dmw038. Hum Reprod Update. 2017. PMID: 27827818 Free PMC article.
-
A randomized controlled trial comparing embryo vitrification with slush nitrogen to liquid nitrogen in women undergoing frozen embryo transfer: embryology and clinical outcomes.Hum Reprod. 2025 Mar 1;40(3):426-433. doi: 10.1093/humrep/deaf003. Hum Reprod. 2025. PMID: 39836897 Clinical Trial.
-
Embryology outcomes of a device-based sperm separation technique compared to density gradient centrifugation using thawed spermatozoa-a sibling donor oocyte study.J Assist Reprod Genet. 2025 Jan;42(1):97-105. doi: 10.1007/s10815-024-03336-x. Epub 2024 Nov 30. J Assist Reprod Genet. 2025. PMID: 39614958
-
ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.J Assist Reprod Genet. 2024 Dec;41(12):3423-3432. doi: 10.1007/s10815-024-03299-z. Epub 2024 Nov 4. J Assist Reprod Genet. 2024. PMID: 39495342
-
Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.Cochrane Database Syst Rev. 2022 May 19;5(5):CD002118. doi: 10.1002/14651858.CD002118.pub6. Cochrane Database Syst Rev. 2022. PMID: 35588094 Free PMC article.
References
-
- Ethics Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril 2018;110(6):1022–8. - PubMed
-
- Johnston M, Richings NM, Leung A, Sakkas D, Catt S. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection [Internet]. Human Reproduction. 2021;36(3):624–35. 10.1093/humrep/deaa320. - PubMed
-
- Goldman KN, Labella PA, Grifo JA, McCulloh D, Noyes N. The evolution of oocyte cryopreservation (OC): longitudinal trends at a single center. Fertil Steril. 2014;102(3):e164–5.
-
- Rienzi L, Cobo A, Paffoni A, Scarduelli C, Capalbo A, Vajta G, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod. 2012;27(6):1606–12. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials